UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 569

Sortiert nach

Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities

Blood, 2007-07, Vol.110 (1), p.201-210

2007

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

American journal of kidney diseases, 2016-04, Vol.67 (4), p.559-566

2016

Link zum Volltext

Verfügbarkeit prüfen

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit

Blood, 2010-01, Vol.115 (4), p.757-765

2010

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Clinical cancer research, 2019-03, Vol.25 (6), p.1718-1726

2019

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment

British journal of clinical pharmacology, 2016-09, Vol.82 (3), p.696-705

2016

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein

The Journal of immunology (1950), 2003-04, Vol.170 (8), p.4196-4200

2003

Link zum Volltext

Verfügbarkeit prüfen

Drifters, Drogues, and Circulation

Oceanography (Washington, D.C.), 2010-12, Vol.23 (4), p.165-172

MANLEY, THOMAS O.

2010

Link zum Volltext

Verfügbarkeit prüfen

MULTIDRUG-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS IN A TODDLER: CHARACTERIZATION OF THE ORGANISM AND SUCCESSFUL TREATMENT WITH INTRAVENTRICULAR DAPTOMYCIN AND INTRAVENOUS TIGECYCLINE

The Pediatric infectious disease journal, 2010-04, Vol.29 (4), p.379-381

2010

Link zum Volltext

Verfügbarkeit prüfen

Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection

Blood, 2004-08, Vol.104 (4), p.1075-1082

2004

Link zum Volltext

Verfügbarkeit prüfen

P815: HIGH VALENCY OF IGM‐2644, A CD38XCD3 IGM BISPECIFIC T CELL ENGAGER, DISPLACES DARATUMUMAB BINDING AND INDUCES POTENT MULTIPLE MYELOMA CELL KILLING

HemaSphere, 2023-08, Vol.7 (S3), p.e630565c-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Generation of HIV-1–specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

Blood, 2008-10, Vol.112 (8), p.3484-3487

2008

Link zum Volltext

Verfügbarkeit prüfen

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

The Lancet (British edition), 2019-01, Vol.393 (10168), p.229-240

2019

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study

Journal of clinical oncology, 2019-11, Vol.37 (33), p.JCO1901492-3089

2019

Link zum Volltext

Verfügbarkeit prüfen

Prescription patterns of long-acting β-agonist monotherapy for patients with asthma

Annals of allergy, asthma, & immunology, 2011-02, Vol.106 (2), p.172-174

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Clinical infectious diseases, 2022-12, Vol.75 (12), p.2079-2087

2022

Link zum Volltext

Verfügbarkeit prüfen

Real World Prevalence of Diagnostic Revision Among Patients with Peripheral T-Cell Lymphomas (PTCL) in the US: Results of an Administrative Claims and Electronic Medical Record Analyses

Blood, 2018-11, Vol.132 (Supplement 1), p.1633-1633

2018

Link zum Volltext

Verfügbarkeit prüfen

Defining Critical Communications Networks: Modelling Networks as Systems

Insight (International Council on Systems Engineering), 2020-06, Vol.23 (2), p.36-42

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of brentuximab vedotin with chemotherapy in treatment of CD30-expressing PTCL

The American journal of managed care, 2020-02, Vol.26 (2), p.e41-e49

2020

Link zum Volltext

Verfügbarkeit prüfen

P-047 Trial in progress: an open-label, multicenter, phase 1 study for IGM-2644 in participants with relapsed and/or refractory multiple myeloma (RRMM)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S60-S61

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e19060-e19060

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient-Centered Quality Measures for Dialysis Care: A Report of a Kidney Disease Outcomes Quality Initiative (KDOQI) Scientific Workshop Sponsored by the National Kidney Foundation

American journal of kidney diseases, 2024-05, Vol.83 (5), p.636-647

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 569

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(484)
Mit Volltextzugriff
(514)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment

T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity

Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein

Drifters, Drogues, and Circulation

MULTIDRUG-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS IN A TODDLER: CHARACTERIZATION OF THE ORGANISM AND SUCCESSFUL TREATMENT WITH INTRAVENTRICULAR DAPTOMYCIN AND INTRAVENOUS TIGECYCLINE

Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection

P815: HIGH VALENCY OF IGM‐2644, A CD38XCD3 IGM BISPECIFIC T CELL ENGAGER, DISPLACES DARATUMUMAB BINDING AND INDUCES POTENT MULTIPLE MYELOMA CELL KILLING

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

Generation of HIV-1–specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study

Prescription patterns of long-acting β-agonist monotherapy for patients with asthma

Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Real World Prevalence of Diagnostic Revision Among Patients with Peripheral T-Cell Lymphomas (PTCL) in the US: Results of an Administrative Claims and Electronic Medical Record Analyses

Defining Critical Communications Networks: Modelling Networks as Systems

Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection

Cost-effectiveness of brentuximab vedotin with chemotherapy in treatment of CD30-expressing PTCL

P-047 Trial in progress: an open-label, multicenter, phase 1 study for IGM-2644 in participants with relapsed and/or refractory multiple myeloma (RRMM)

Pharmacodynamics and Biomarker Correlates of Imvotamab (IGM-2323), the First-in-Class CD20xCD3 Bispecific IgM Antibody with Dual Mechanisms of Action, in Patients with Advanced B Cell Malignancies

Cost-Effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma

Patient-Centered Quality Measures for Dialysis Care: A Report of a Kidney Disease Outcomes Quality Initiative (KDOQI) Scientific Workshop Sponsored by the National Kidney Foundation

Suchergebnisse filtern